Laurus Labs acquires stake in Indian CAR-T therapy developer ImmunoACT
Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an Indian cell and gene therapy company for a sum of around INR 46 crores in cash. Apart from that, ImmunoACT will also get an investment of INR 9.75 crores from its senior management for a stake […]